UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities
Exchange Act of 1934
(Amendment No. )
Filed by the
Registrant x
Filed by a party other than the
Registrant o
Check the appropriate box:
o Preliminary
Proxy Statement
o Confidential,
for Use of the Commission Only (as permitted by
Rule 14a-6(e)(2))
o Definitive
Proxy Statement
x Definitive
Additional Materials
o Soliciting
Material Pursuant to
§ 240.14a-12
FOREST LABORATORIES, INC.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy
Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
| x | No fee required. |
| o | Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. |
| (1) | Title of each class of securities to which transaction applies: |
| (2) | Aggregate number of securities to which transaction applies: |
(3) Per unit price or other underlying value of transaction
computed pursuant to Exchange Act
Rule 0-11
(set forth the amount on which the filing fee is calculated and
state how it was determined):
(4) Proposed maximum aggregate value of transaction:
(5) Total fee paid:
o Fee
paid previously with preliminary materials.
o Check
box if any part of the fee is offset as provided by Exchange Act
Rule 0-11(a)(2)
and identify the filing for which the offsetting fee was paid
previously. Identify the previous filing by registration
statement number, or the Form or Schedule and the date of its
filing.
(1) Amount Previously Paid:
(2) Form, Schedule or Registration Statement No.:
(3) Filing Party:
(4) Date Filed:
| Presentations & Materials Forest 2011 Annual Meeting — Windows Internet Explorer • I Si http://www.frx2D 1 lannualmeeting.eorn.presentations-matErialg/ ‘ ile Edit View Favorites Tools Helpc Co,«jle V J Search — • More » _ Sign In <\ — X * ^Favorites ^ f!j Best of the Web f!j Channel Guide f!j Free Hotmail je_, Internet Explorer News £_, Internet Start g] Web Slice Gallery — f£ Presentations a Materials Forest 2D11 Annual Meeting Page » Safety ~ Tools — Forest Laboratories, Inc. Visitfrjt.com Home Press Releases Shareholder Letters Presentations & Materials Our Nominees Proxy Materials SEC Filings Contact Presentations & MaterialsTitleDate08.05.2011Forest Labs-A Leading Pharmaceutical Company08.04.2011 Icahn’s Augjsf. 3rd Claims are Filled with Misrepresentations07.28.2011 For&sf Labs -A Leading Pnarma Company 06.13.2011 Submission on B&rialf of Howard Solomon to trie HHS-DIG from Davis Polk a Wardw&ll LLP 04.05.2011 FRX Board Meeting Minutes from April 5, 201103.29.2011 FRK Presentation to the HHS-OIC from Debevoise & Plimpton LLP |
| //www.frx2Qllannual meeting. com/presentations-materials/ File Edit View Favorites Tools Help Favorites Presentations & Materials I Forest 2011 Annual M,., Page Safety Tools Miinmcs 11 um 03.29.2011 FRX Presentation to the HHS-QIG from Debevoise & Plimpton LLP Letters Date Title 08052011 Case Closure Letter to Howard Solomon from the HHS-QIG 07.25.2011 Letter from Dr. Jorge Gallardo. Chairman of the Board. Almirall 07.18.2011 06.23.2011 06.15.2011 Letter from Peter M. Hecht. CEO, Ironwood Pharmaceuticals Letter from Lisa A. Richard. President. U.S. Chamber Institute for Legal Reform Letter from John J. Castellani. President and CEO. PhRMA 04.18.2011 Letter from Dr. Jochen Huchmann. Shareholders’ Council. Merz 04.08.2011 Letter from Peter Clark. Office of Inspector General. Petit, of Health & Human Services 03.30.2011 FRX Letter to the HHS-OIGfrom Debevoise & Plimpton LLP News Reoorts |
| 06.15.2011 Letter from John j. Castellani, President and CEO, PhRMA 04.18.2011 Letter from Dr. Jochen Huckmann, Shareholder’s Council, Merz 04.08.2011 Letter from Peter Clark, Office of Inspector General, Dept, of Health & Human Services 03.30.2011 FRX Letter to the HHS-OIG from Debevoise & Plimpton LLP |
| News Reports |
| Date Title 05.05.2001 “Forest firing-The Government seeks to sack an innocent boss” — The Econimist 05.02.2011 “Kathleen Spitzer” — The Wall STreet Journal 04.29.2011 “The Goverments’s Power to Oust a C.E.O.” — DeaBook, The New York Times 04.26.2011 “U.S.Effort to Remove Drug CEO Jolts Firms” — The Wall Street Journal |